The Role of Iron in Outpatient CKD Management

ASN Renal Week 2009 Official Symposium
Welcome and Introductions
George Aronoff , MD

Iron and Clinical Outcomes in CKD Patients
Csaba P. Kovesdy, MD

Is my Patient Iron Deficient: What do I Measure?
Jay Wish, MD

Optimizing Iron Therapy in Outpatient CKD Patients: Past, Present, and Future
Daniel W. Coyne, MD

Questions and Answers
Drs. Kovesdy,  Wish, and Coyne




George Aronoff, MD (Moderator)
Chief, Division of Nephrology,
Department of Medicine,
Professor of Medicine and Pharmacology,
University of Louisville School of Medicine,
Louisville, KY

Csaba P. Kovesdy, MD
Chief, Division of Nephrology
Salem Veterans Administration Medical Center
Salem, VA

Jay B. Wish, MD
Professor of Medicine
Case Western Reserve University
Medical Director of Hemodialysis Unit
University Hospitals of Cleveland
Cleveland,OH

Daniel W. Coyne, MD
Professor of Medicine
Washington University School of Medicine
St. Louis, MO

This group of talks is accredited for up to 1.5 AMA PRA Category 1 credits™. This group of talks has a single post-test, which must be completed along with an evaluation form to obtain credit. The links to the post-test appear on the individual talk pages.
Date of Web Release: November 30, 2009
CME Credit Eligible Through: April 30, 2011
AMA PRA Category 1 Credits™: 1.5
Target Audiences: Physicians, Researchers and Fellows-in-Training.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

OVERVIEW :
Iron has become a fundamental factor in the assessment and management of anemia of chronic kidney disease (CKD). A major clinical issue is the detection and treatment of relative iron deficiency. This symposium will first review epidemiologic data regarding outcomes associated with abnormal iron metabolism in CKD patients. The laboratory strategy for assessing iron status will then be reviewed. The optimal strategy for iron therapy in the outpatient CKD patient will be reviewed contrasting past and current management with future approaches.

ACCREDITATION AND DESIGNATION STATEMENTS:
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Credit Designation Statement:
The American Society of Nephrology designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in each portion of this activity.

SPONSORSHIP / SUPPORT :
Support for this session is provided by an educational grant from AMAG Pharmaceuticals, Inc.

FACULTY DISCLOSURE STATEMENTS :
It is the policy of ASN that all individuals in a position to control the content of ASN's sponsored CME activities are expected to provide full disclosure for both themselves and their spouse/partner, and indicate to the activity audience any relevant financial or other relationships held by themselves or their spouse/partner 1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial service(s) discussed in an educational presentation; and 2) with any commercial supporter(s) of the activity. All responses should reflect activities within the previous 12 months. This disclosure information is collected in accordance with the Accreditation Council for Continuing Medical Education (ACCME). Further, ASN requires that all faculty disclose at the time of their lecture, any planned discussion of investigational and/or off-label use of pharmaceutical products or devices within their presentation. Participants should note that the use of products outside U.S. Food and Drug Administration (FDA) approved labeling should be considered experimental and are advised to consult current prescribing information for approval indications.

The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in continuing medical education (CME), but rather to ensure that ASN CME activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. In addition, all faculty members were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.

Faculty disclosures are posted on each individual talk page.

DISCLOSURE OF UNLABELED USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Faculty disclosure about unlabeled or off-label use is posted on each individual talk page.

ASN's PRIVACY/CONFIDENTIALITY POLICY:
As a condition of your access and use of the Website, you agree not to use the Website for any purpose that is unlawful or inconsistent with the Agreement. ASN, in its sole discretion, is authorized to remove or delete any entries, information, materials or other content that violates these Terms of Use or that is otherwise objectionable. ASN reserves the right to investigate and prosecute violations of any of these Terms of Use to the fullest extent of the law. If Users fail to comply with these Terms of Use, ASN in its sole discretion may terminate the User's access to the website immediately without advance notice. These terms of use comprise an Agreement that is governed by the laws of the District of Columbia, which shall be the forum for any disputes.

DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

USER INSTRUCTIONS:
To complete this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player (download from www.microsoft.com) or the Flash version 8.0 (download from www.adobe.com) is required, and either can be downloaded for free per instructions on the individual lecture pages. Flash version 8.0 is required for the full-screen slide version of the program. Acrobat Reader is required to print the CME certificate, and this can be download free from www.adobe.com.

For any questions concerning this specific activity please send an email to or email@asn-online.org, or call HDCN at 630-325-3276 during normal business hours, Chicago time (Central Standard Time).

For any general questions concerning ASN CME, please contact the American Society of Nephrology.